Using Cannabidiol-Enriched Cannabis to Treat Pediatric Treatment-Resistant Epilepsy
Posted by Marijuana Doctors on 11/28/2016 in Medical Marijuana Studies
Treatment-resistant epilepsy has a significant impact on quality of life, behavioral function, and cognitive function in pediatric patients, and treating these seizures poses some unique challenges that leave parents frustrated. Many of the current treatments don’t work well on pediatric intractable epilepsies, and some medications have so many side effects that they have the potential to leave children in a near catatonic state. For this reason, cannabidiol-enriched medical cannabis has received a lot of attention within the past several years.
Studies and anecdotal evidence show significant medical marijuana benefits for pediatric patients suffering from treatment-resistant epilepsy, offering strong evidence for the anticonvulsant properties and safety of cannabidiol (CBD). Here’s a closer look at both anecdotal evidence and research supporting cannabidiol-enriched cannabis, as well as a look at how cannabis peer review studies can offer more help and hope for pediatric patients and their families.
The Charlotte Figi Story and Charlotte’s Web
While being well-known among the cannabis community, the Charlotte Figi story remains one of the most compelling stories surrounding the use of cannabidiol-enriched cannabis for pediatric patients with treatment-resistant epilepsy. As a young child, Charlotte was having more than 1,000 seizures a month, and even after trying multiple medications and extreme diets, nothing was working. More than once, her parents had to use life-saving procedures to bring her back to life after rescue medications stopped her breathing.
Out of desperation, her parents decided to give medical marijuana a try, and with great results. After treating Charlotte with a special marijuana strain, specifically cultivated to be low in TCH and high in CBD, Charlotte generally only has a couple seizures a month, and the ones she does have are far less severe. Created by the Stanley brothers, this unique high-CBD strain of marijuana is now known as “Charlotte’s Web,” and more than 40 pediatric patients with treatment-resistant epilepsy are now using Charlotte’s Web with great success.
Research Supporting the Use of Cannabidiol-Enriched Cannabis
Surveys and studies also back up the use of cannabidiol-enriched cannabis for pediatric patients with epilepsy that doesn’t respond to other treatments. One survey offered to parents of children with treatment-resistant epilepsy showed how successful cannabidiol-enriched cannabis can be. 84% of parents surveyed noted that their child had a significant reduction in the frequency of their seizures, and 11% reported complete freedom from seizures after using cannabidiol-enriched cannabis.
Another retrospective study took a look at cannabidiol-enriched medical cannabis and its effects on 74 children with treatment-resistant epilepsy, finding that CBD treatment had a very positive effect. This study found that 89% of the children involved had a reduction in seizure frequency, with 18% of those children seeing 75-100% reduction in the frequency of their seizures. Other improvements pediatric patients reported included better alertness, communication, sleep, behavior, motor skills, and language. The study concluded that the use of CBD for treating intractable epilepsy in children is highly promising and one of the best potential medical marijuana uses out there.
Cannabis Peer Review Studies Offer Help and Hope for Pediatric Patients
While anecdotal evidence and some research does support the use of medical marijuana, specifically cannabidiol-enriched cannabis, to treat pediatric patients with treatment-resistant epilepsy, further studies, such as cannabis peer review studies can help. One new peer review study is offering helpful information for patients, patient family members, and physicians. Not only will this study provide help and hope for pediatric patients interested in a medical cannabis card, but it will also allow physicians to get involved, letting them monitor the progress of pediatric patients as they begin using medical marijuana. Parents will also be able to track the progress of their child, since the study’s mobile app makes it easy to capture important data relevant to the medical condition of their child.
If your child has a medical marijuana card, you can offer help to other parents and their children today by signing up to get involved in this cannabis peer-review study. By getting involved, you and your child can be instrumental in helping doctors and other patients learn more about how cannabidiol works in pediatric patients with treatment-resistant epilepsy.